Eliquis 5 MG tablet 74S
Ended Awarded Last action
- Contract number
- SPE2DR26FCY6R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,825
Award facts
- Contract value 100% obligated
- $36,825.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,825.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 74 tablets of ELIQUIS 5 mg, with an ultimate completion date of January 9, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of brand-name and generic medications, specialty pharmaceuticals, vaccines, and related medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. ELIQUIS is an anticoagulant medication commonly used in military treatment facilities and veterans' healthcare programs. This delivery order reflects the routine pharmaceutical supply operations under the DLA's pharmaceutical prime vendor program, which supports the Defense Health Agency and other government healthcare systems with essential medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FCY6R?
SPE2DR26FCY6R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FCY6R worth?
The government has obligated $36,825 on SPE2DR26FCY6R.
Is contract SPE2DR26FCY6R an order under another contract?
Yes. SPE2DR26FCY6R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY6R competed?
The extent of competition for SPE2DR26FCY6R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award